1. Home
  2. AVNT vs BLLN Comparison

AVNT vs BLLN Comparison

Compare AVNT & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avient Corporation

AVNT

Avient Corporation

HOLD

Current Price

$37.91

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$118.17

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVNT
BLLN
Founded
1927
2016
Country
United States
United States
Employees
N/A
713
Industry
Major Chemicals
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.9B
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
AVNT
BLLN
Price
$37.91
$118.17
Analyst Decision
Hold
Buy
Analyst Count
5
7
Target Price
$41.50
$126.71
AVG Volume (30 Days)
788.8K
782.3K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
3.04%
N/A
EPS Growth
N/A
N/A
EPS
0.61
N/A
Revenue
$3,835,500,000.00
N/A
Revenue This Year
$4.90
$46.29
Revenue Next Year
$3.48
$30.14
P/E Ratio
$60.66
N/A
Revenue Growth
1.71
N/A
52 Week Low
$27.48
$61.96
52 Week High
$44.85
$138.70

Technical Indicators

Market Signals
Indicator
AVNT
BLLN
Relative Strength Index (RSI) 55.69 67.16
Support Level $35.34 $79.07
Resistance Level $37.22 $138.70
Average True Range (ATR) 1.16 6.87
MACD 0.11 1.10
Stochastic Oscillator 69.61 97.91

Price Performance

Historical Comparison
AVNT
BLLN

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The color, additives, & ink segment and the distribution segment together generate a vast majority of revenue. More than half of the total revenue is derived from the United States.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: